Organization · Other
Venture Valuation AG
Venture Valuation AG is a financial services company based in Switzerland, specializing in independent valuations for companies and products in the life sciences sector. Founded in 1999, it serves clients globally, including investors and technology firms.
Overview
What Venture Valuation AG does
What Venture Valuation AG is
Venture Valuation AG is a financial services company based in Switzerland, specializing in independent valuations for companies and products in the life sciences sector. Founded in 1999, it serves clients globally, including investors and technology firms.
How it participates in the startup ecosystem
The current public profile supports funder and event host and publisher capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Other
- Founded
- Founded in 1999
- Approximate age
- About 27 years
- Structured capabilities
- Funder · Event host · Publisher
- Last reviewed
- March 16, 2026
Official channels
Find Venture Valuation AG elsewhere
Open the official website or a supported primary organization account.
Capability profile
Venture Valuation AG as a funder
Investment thesis
Venture Valuation AG specializes in independent asset and company valuations, focusing on technology companies in fast-growing markets, particularly in life sciences.
Focus narrative
Venture Valuation provides valuation services for companies and products, particularly in the life sciences sector. Their services include company and product valuation, investment analysis, and monitoring for investors. They utilize various valuation methods, including discounted cash flow (DCF), risk-adjusted net present value (rNPV), and market comparable methods. Their clients include both investors and companies seeking financing.
Value beyond capital
Venture Valuation adds value to portfolio companies through comprehensive valuation services, investment analysis, and monitoring, helping clients make informed financial decisions.
Focus and fit
- Regions
- Asia · Europe · Global · North America
Availability
- Currently deploying
- Not published
Portfolio and track record
Portfolio context
Venture Valuation has worked with a diverse range of clients, including investors such as the European Investment Bank (EIB), Novartis Venture Fund, GSK CEEDD, and ZKB Asset Management, as well as companies like Idorsia Pharmaceuticals, Aprilbio Inc., Axxam SpA, and Integra Biosciences.
Capability profile
Venture Valuation AG as an event host
Event focus
Venture Valuation provides valuation services for companies and products, particularly in the life sciences sector. Their services include company and product valuation, investment analysis, and monitoring for investors. They utilize various valuation methods, including discounted cash flow (DCF), risk-adjusted net present value (rNPV), and market comparable methods.
Participant value
Venture Valuation specializes in independent asset and company valuations, focusing primarily on technology companies in fast-growing markets, particularly in the life sciences sector.
Format and cadence
- Event types
- conference and summit
- Startups can present
- No
Availability
- Registration state
- Not currently accepting
Audience and fit
- Audience
- Founders · Investors
- Regions
- Europe · Global
Capability profile
Venture Valuation AG as a publisher
Editorial focus
Venture Valuation AG specializes in independent asset and company valuations, focusing primarily on technology companies in fast-growing markets, particularly in the life sciences sector. Their services include company and product valuation, investment analysis, and monitoring for investors, utilizing various valuation methods such as discounted cash flow (DCF) and risk-adjusted net present value (rNPV).
Audience value
Venture Valuation provides essential valuation services for investors and companies in the life sciences sector, helping them make informed investment decisions and secure financing.
Format and cadence
- Content formats
- research-report and blog
Availability
- Guest pitch state
- Not currently accepting
Audience and focus
- Audience
- Investors · Founders
- Regions
- Europe · Global
Flagship work and coverage
Flagship properties
Venture Valuation publishes the 'Life Sciences M&A Report' and conducts interviews with leaders in the life sciences industry.
Notable coverage
Venture Valuation has worked with notable clients including the European Investment Bank, Novartis Venture Fund, and Idorsia Pharmaceuticals.
Common questions
What to know about Venture Valuation AG
Upseed classifies Venture Valuation AG under the Other organization type. Its current public profile includes funder, event host, and publisher capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 16, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.